Note 3 - Balance Sheet Details

3 Months Ended

Mar. 31, 2022

Disclosure Text Block [Abstract]

Balance Sheet Details

. Balance Sheet Details

Accrued liabilities consisted of the following (in thousands):

	March 31,		December 31,
	2022		2021
Accrued accounts payable	$	399	$	195
Accrued clinical trial costs		69		158
Accrued director stipends		112		110
	$	580	$	463

Prepaid expenses and other current assets consisted of the following (in thousands):

	March 31,		December 31,
	2022		2021
Prepaid insurance	$	1,120	$	1,408
Other receivables		86		150
Prepaid subscriptions and fees		210		215
Prepaid software licenses		90		78
Deposits		26		26
Deferred equity costs		82		—
Prepaid other		—		2
	$	1,614	$	1,879